Alison S. Long

Chief Medical Officer, Kaleido Biosciences, Inc.

Companies

Taysha Gene Therapies, Inc.Board member Nov 3, 2023 to now¹
Kaleido Biosciences, Inc.Chief Medical Officer Dec 16, 2021 to Jan 18, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Taysha Gene Therapies, Inc. TSHA127,178 shares³$503.0K at $3.96Jun 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 1, 2026Granted 21,335 shares of Taysha Gene Therapies, Inc.³
Jun 2, 2025Granted 56,623 shares of Taysha Gene Therapies, Inc.⁴
May 29, 2024Granted 49,220 shares of Taysha Gene Therapies, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTaysha Gene Therapies, Inc., Board member
2
SEC EDGARKaleido Biosciences, Inc., Chief Medical Officer
3
SEC EDGARTaysha Gene Therapies, Inc. shares after the filing of Jun 1, 2026
4
SEC EDGARForm 4 filed Jun 4, 2025
5
SEC EDGARForm 4 filed May 31, 2024